Omega 3 fatty acids and the brain: review of studies in depression.

The brain is a lipid-rich organ containing mostly complex polar phospholipids, sphingolipids, gangliosides and cholesterol. These lipids are involved in the structure and function of cell membranes in the brain. The glycerophospholipids in the brain contain a high proportion of polyunsaturated fatty acids (PUFA) derived from the essential fatty acids, linoleic acid and alpha-linolenic acid. The main PUFA in the brain are docosahexaenoic acid (DHA, all cis 4,7,10,13,16,19-22:6) derived from the omega 3 fatty acid, alpha-linolenic acid, and arachidonic acid (AA, all cis 5,8,11,14-20:4) and docosatetraenoic acid (all cis 7,10,13,16-22:4), both derived from the omega 6 fatty acid, linoleic acid. Experimental studies in animals have shown that diets lacking omega 3 PUFA lead to substantial disturbances in neural function, which in most circumstances can be restored by the inclusion of omega 3 PUFA in the diet. In the past 10 years there has been an emerging interest in treating neuropsychological disorders (depression and schizophrenia) with omega 3 PUFA. This paper discusses the clinical studies conducted in the area of depression and omega 3 PUFA and the possible mechanisms of action of these PUFA. It is clear from the literature that DHA is involved in a variety of processes in neural cells and that its role is far more complex than simply influencing cell membrane properties.

[1]  Rex E. Martin.  Docosahexaenoic acid decreases phospholipase A2 activity in the neurites/nerve growth cones of PC12 cells , 1998, Journal of neuroscience research.

[2]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[3]  L Svennerholm,et al.  Distribution and fatty acid composition of phosphoglycerides in normal human brain. , 1968, Journal of lipid research.

[4]  S. Rapoport,et al.  One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats Published, JLR Papers in Press, October 6, 2005. , 2006, Journal of Lipid Research.

[5]  J. Hibbeln.  Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. , 2002, Journal of affective disorders.

[6]  Russo-Neustadt Aa,et al.  Brain-derived neurotrophic factor and antidepressant activity. , 2005, Current pharmaceutical design.

[7]  L. Marangell,et al.  Omega‐3 fatty acids for the prevention of postpartum depression: Negative data from a preliminary, open‐label pilot study , 2004, Depression and anxiety.

[8]  M. Crawford,et al.  The long chain metabolites of linoleic avid linolenic acids in liver and brain in herbivores and carnivores. , 1976, Comparative biochemistry and physiology. B, Comparative biochemistry.

[9]  S. O’Mara,et al.  Deficits in spatial learning and synaptic plasticity induced by the rapid and competitive broad‐spectrum cyclooxygenase inhibitor ibuprofen are reversed by increasing endogenous brain‐derived neurotrophic factor , 2003, The European journal of neuroscience.

[10]  F. Gomez-Pinilla,et al.  Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. , 2004, Journal of neurotrauma.

[11]  D. Guilloteau,et al.  The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. , 2002, The American journal of clinical nutrition.

[12]  A. Sinclair,et al.  Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression , 2007, Lipids.

[13]  T. Montine,et al.  Quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. , 2001, Advances in experimental medicine and biology.

[14]  M. Wichers,et al.  The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. , 2002, The international journal of neuropsychopharmacology.

[15]  M. Cuesta,et al.  [Neurobiology of depression]. , 2002, Anales del sistema sanitario de Navarra.

[16]  H. Meltzer,et al.  Lowered ω3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients , 1999, Psychiatry Research.

[17]  N. Bazan.  Neuroprotectin D1 (NPD1): A DHA‐Derived Mediator that Protects Brain and Retina Against Cell Injury‐Induced Oxidative Stress , 2005, Brain pathology.

[18]  B. Penninx,et al.  Depression and cardiac mortality: results from a community-based longitudinal study. , 2001, Archives of general psychiatry.

[19]  C. L. Jensen,et al.  Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. , 2003, American journal of obstetrics and gynecology.

[20]  R. Belmaker,et al.  Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. , 2002, The American journal of psychiatry.

[21]  F. Calderon,et al.  Docosahexaenoic acid promotes neurite growth in hippocampal neurons , 2004, Journal of neurochemistry.

[22]  P. Calder,et al.  n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. , 2006, The American journal of clinical nutrition.

[23]  L. Puskás,et al.  Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  N. Salem,et al.  A Decrease in Cell Size Accompanies a Loss of Docosahexaenoate in the Rat Hippocampus , 2002, Nutritional neuroscience.

[25]  Yong-Ku Kim,et al.  The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder. , 2006, International immunopharmacology.

[26]  Alan Grossfield,et al.  A role for direct interactions in the modulation of rhodopsin by ω-3 polyunsaturated lipids , 2006 .

[27]  R. Bowen,et al.  Dietary low linolenic acid compared with docosahexaenoic acid alter synaptic plasma membrane phospholipid fatty acid composition and sodium–potassium ATPase kinetics in developing rats , 2002, Journal of neurochemistry.

[28]  K. Hashimoto,et al.  Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants , 2003, Biological Psychiatry.

[29]  S. Rapoport,et al.  Chronic Carbamazepine Decreases the Incorporation Rate and Turnover of Arachidonic Acid but Not Docosahexaenoic Acid in Brain Phospholipids of the Unanesthetized Rat: Relevance to Bipolar Disorder , 2006, Biological Psychiatry.

[30]  B. Davletov,et al.  Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3 , 2006, Nature.

[31]  R. Deckelbaum,et al.  n-3 fatty acids and gene expression. , 2006, The American journal of clinical nutrition.

[32]  J. Depierre,et al.  Tricyclic antidepressants inhibit IL-6, IL-1β and TNF-α release in human blood monocytes and IL-2 and interferon-γ in T cells , 1996 .

[33]  Y. Osher,et al.  Omega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label study. , 2005, The Journal of clinical psychiatry.

[34]  M. Frye,et al.  Double-Blind, Randomized, Placebo-Controlled Trials of Ethyl-Eicosapentanoate in the Treatment of Bipolar Depression and Rapid Cycling Bipolar Disorder , 2006, Biological Psychiatry.

[35]  Zhiming Wen,et al.  Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. Rapoport,et al.  Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E2 concentration in rat brain , 2002, Molecular Psychiatry.

[37]  K. Silvers,et al.  Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[38]  F. Gomez-Pinilla,et al.  Exercise reverses the harmful effects of consumption of a high-fat diet on synaptic and behavioral plasticity associated to the action of brain-derived neurotrophic factor , 2004, Neuroscience.

[39]  Alan Grossfield,et al.  A role for direct interactions in the modulation of rhodopsin by omega-3 polyunsaturated lipids. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[40]  F. Pifferi,et al.  (n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter GLUT1 in rats. , 2005, The Journal of nutrition.

[41]  J. Depierre,et al.  Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. , 1996, Immunopharmacology.

[42]  S. Frangou,et al.  Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: Randomised double-blind placebo-controlled study , 2006, British Journal of Psychiatry.

[43]  D. Guilloteau,et al.  Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. , 2000, Journal of lipid research.

[44]  B. Roth,et al.  Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗ ∗ See accompanying Editorial, in this issue. , 1999, Biological Psychiatry.

[45]  D. Horrobin,et al.  A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. , 2002, Archives of general psychiatry.

[46]  C. Serhan,et al.  Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells , 2003, The Journal of Biological Chemistry.

[47]  D. C. Mitchell,et al.  The role of docosahexaenoic acid containing phospholipids in modulating G protein-coupled signaling pathways , 2001, Journal of Molecular Neuroscience.

[48]  J. Hibbeln,et al.  Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. , 1995, The American journal of clinical nutrition.

[49]  Peter Herscovitch,et al.  Regional cerebral glucose utilization in patients with a range of severities of unipolar depression , 2002, Biological Psychiatry.

[50]  D. Guilloteau,et al.  Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. , 1998, The Journal of nutrition.

[51]  S. Rapoport,et al.  Chronic lithium chloride administration to rats elevates glucose metabolism in wide areas of brain, while potentiating negative effects on metabolism of dopamine D2-like receptor stimulation , 2006, Psychopharmacology.

[52]  G. Barceló-Coblijn,et al.  Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[53]  K. Scott,et al.  Fish consumption and self-reported physical and mental health status , 2002, Public Health Nutrition.

[54]  Kaori Matsumoto,et al.  Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures , 2004, FEBS letters.

[55]  S. Rapoport,et al.  Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex , 2007, Molecular Psychiatry.

[56]  R. Sapolsky,et al.  The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death , 2000, Biological Psychiatry.

[57]  S. Rapoport,et al.  Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl–CoA by brain microsomal long-chain fatty acyl–CoA synthetases: relevance to bipolar disorder , 2005, Psychopharmacology.

[58]  B. Puri,et al.  EICOSAPENTAENOIC ACID IN TREATMENT‐RESISTANT DEPRESSION ASSOCIATED WITH SYMPTOM REMISSION, STRUCTURAL BRAIN CHANGES AND REDUCED NEURONAL PHOSPHOLIPID TURNOVER , 2001, International journal of clinical practice.

[59]  M. Chen,et al.  Brain-derived neurotrophic factor and antidepressant activity. , 2005, Current pharmaceutical design.

[60]  J. Sontrop,et al.  Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique. , 2006, Preventive medicine.

[61]  F. Gomez-Pinilla,et al.  A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning , 2002, Neuroscience.

[62]  J. Hibbeln,et al.  Cross-national comparisons of seafood consumption and rates of bipolar disorders. , 2003, The American journal of psychiatry.

[63]  S. Rapoport,et al.  Chronic Lithium Chloride Administration to Unanesthetized Rats Attenuates Brain Dopamine D2-Like Receptor-Initiated Signaling Via Arachidonic Acid , 2005, Neuropsychopharmacology.

[64]  K. Honkalampi,et al.  Fish consumption, depression, and suicidality in a general population. , 2001, Archives of general psychiatry.

[65]  S. Rapoport,et al.  n-3 Polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism , 2007, Molecular Psychiatry.

[66]  L. Marangell,et al.  A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. , 2003, The American journal of psychiatry.

[67]  K. Su,et al.  O fatty acids in major depressive disorder A preliminary double-blind, placebo-controlled trial , 2003 .

[68]  P. Sastry,et al.  Regulation of diacylglycerol kinase in rat brain membranes by docosahexaenoic acid , 1994, Neuroscience Letters.

[69]  A. Stoll,et al.  Omega 3 Fatty Acids in Bipolar Disorder A Preliminary Double-blind, Placebo-Controlled Trial , 1999 .

[70]  Heikki Tanila,et al.  Brain reward in the absence of alpha-synuclein , 2006, Neuroreport.

[71]  J. Soares,et al.  Relationship between regional cerebral blood flow and separate symptom clusters of major depression: A single photon emission computed tomography study using statistical parametric mapping , 2005, Neuroscience Letters.

[72]  A. Nitta,et al.  Dietary n-3 fatty acid deficiency decreases nerve growth factor content in rat hippocampus , 2000, Neuroscience Letters.

[73]  M. Lavialle,et al.  Glucose transport and utilization are altered in the brain of rats deficient in n‐3 polyunsaturated fatty acids , 2002, Journal of neurochemistry.